Comparison · NCT03241030-9e1b9e73
Experimental Group vs Placebo Group: Number of Participants With Unscheduled Visits
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Experimental Group vs Placebo Group: Number of Participants With Unscheduled Visits. Trial comparisons, record NCT03241030-9e1b9e73. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03241030-9e1b9e73
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0816 | 0.0322 | 0.192 | wilson | |
| Risk in group 2 | 0.118 | 0.0551 | 0.234 | wilson | |
| Risk difference, group 1 minus group 2 | -0.036 | -0.162 | 0.0908 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.694 | 0.208 | 2.31 | log | |
| Odds ratio, group 1 over group 2 | 0.667 | 0.176 | 2.52 | log | |
| Number needed to treat, for one fewer participant with the outcome on Experimental Group than on Placebo Group | 27.8 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Experimental Group | Subjects will receive sucralfate~Sucralfate: Will receive 20mg/kg/dose up to 1 gram.~Acetaminophen: All patients will receive analgesia, either acetaminophen 15mg/kg or ibuprofen 10mg/kg depending on medication administration prior to arrival in the Emergency Department and at the discretion of the treating physician, in addition to either the experimental drug or placebo.~Ibuprofen: All patients will receive analgesia, either acetaminophen 15mg/kg or ibuprofen 10mg/kg depending on medication administration prior to arrival in the Emergency Department and at the discretion of the treating physician, in addition to either the experimental drug or placebo. | 4 | 49 | OG000 |
| Group 2 | Placebo Group | Subjects will receive a placebo~Placebo: Will received placebo solution of similar quantity to that of the weight based dose of sucralfate.~Acetaminophen: All patients will receive analgesia, either acetaminophen 15mg/kg or ibuprofen 10mg/kg depending on medication administration prior to arrival in the Emergency Department and at the discretion of the treating physician, in addition to either the experimental drug or placebo.~Ibuprofen: All patients will receive analgesia, either acetaminophen 15mg/kg or ibuprofen 10mg/kg depending on medication administration prior to arrival in the Emergency Department and at the discretion of the treating physician, in addition to either the experimental drug or placebo. | 6 | 51 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Unscheduled Visits
- Description
- Will call families to find out about any unscheduled visits.
- Time frame
- Approximately 72 hours from ED visit
- Population
Source ClinicalTrials.gov
Trial
- Title
- Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial
- NCT number
- NCT03241030
- Phases
- PHASE2
- Conditions
- Herpangina, Gingivostomatitis, Hand, Foot and Mouth Disease
- Interventions
- Sucralfate, Placebo, Acetaminophen, Ibuprofen
- Lead sponsor
- University of Texas at Austin
- Results first posted
- 2021-10-29
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03241030?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03241030-9e1b9e73